Global Long Acting Drug Delivery Technologies Services Market Size is valued at USD 13.7 Bn in 2023 and is predicted to reach USD 30.2 Bn by the year 2031 at a 10.6% CAGR during the forecast period for 2024-2031. The global long-acting drug delivery technologies and services market is witnessing robust growth due to the demand for improved patient adherence and therapeutic outcomes. Long-acting formulations, including injectables and implants,...
Report ID: 2565 |
Delivery: Immediate |
Published: July 2024 |
No. of Pages: 180
Cytotoxic Drugs and HPAPI Manufacturing Market Size is valued at USD 10.7 Bn in 2023 and is predicted to reach USD 27.1 Bn by the year 2031 at an 12.5% CAGR during the forecast period for 2024-2031. Cytotoxic drugs and high-potency active pharmaceutical ingredients (HPAPIs) are essential components in modern medicine, known for their potent biological activity at low concentrations. They are instrumental in treating cancers, respiratory ailmen...
Report ID: 2557 |
Delivery: Immediate |
Published: July 2024 |
No. of Pages: 180
Insulin-like Growth Factors Market Size is valued at USD 275.1 Mn in 2023 and is predicted to reach USD 406.1 Mn by the year 2031 at an 5.13% CAGR during the forecast period for 2024-2031. Insulin-like growth factors (IGFs) are proteins that resemble insulin in structure and share some of its effects. Their primary function, however, is to stimulate cell growth and development throughout the body, forming part of a complex system known as the ...
Report ID: 2561 |
Delivery: Immediate |
Published: July 2024 |
No. of Pages: 180
Human-Induced Pluripotent Stem Cells (hiPSCs) Preclinical Disease Model Market Size is predicted to grow at an 11.2% CAGR during the forecast period for 2024-2031. Human-induced pluripotent stem cells (hiPSCs) are a pivotal tool in biomedical research, particularly for preclinical disease modelling and drug development. Derived from adult somatic cells like skin or blood cells, hiPSCs are reprogrammed to an embryonic-like pluripote...
Report ID: 2556 |
Delivery: Immediate |
Published: July 2024 |
No. of Pages: 180
VEGFR-1 Inhibitors Market Size is predicted to grow at a 7.0% CAGR during the forecast period for 2024-2031. VEGFR-1 inhibitors are essential in treating various cancers by targeting the vascular endothelial growth factor receptor-1, which is crucial for angiogenesis and tumor growth. The increasing prevalence of cancer and advancements in targeted therapies are expected to drive the adoption of VEGFR-1 inhibitors. Additionally, ongoing resear...
Report ID: 2552 |
Delivery: Immediate |
Published: June 2024 |
No. of Pages: 180
Cephalosporin API Market Size is valued at USD 1.70 billion in 2023 and is predicted to reach USD 2.62 billion by the year 2031 at a 5.7% CAGR during the forecast period for 2024-2031. Cephalosporin APIs are the active pharmaceutical ingredients derived from fungi, specifically Acremonium, and they form the basis of cephalosporin antibiotics like cephalexin and ceftriaxone. These APIs are crucial for treating bacterial infections and undergo r...
Report ID: 2547 |
Delivery: Immediate |
Published: June 2024 |
No. of Pages: 180
Nucleic Acid Therapeutics Market Size is valued at USD 4.93 billion in 2023 and is predicted to reach USD 13.86 billion by the year 2031 at a 13.8% CAGR during the forecast period for 2024-2031. Nucleic acid therapeutics stands for a group of medicinal interventions that prevent illness by means of nucleic acids. Cutting-edge and focused therapies for a broad spectrum of hereditary and chronic diseases are now available through gene-targeting ...
Report ID: 2548 |
Delivery: Immediate |
Published: June 2024 |
No. of Pages: 180
Thymidylate Synthase Inhibitor Market Size is predicted to grow at a 6.0% CAGR during the forecast period for 2024-2031. Thymidylate synthase inhibitors disrupt DNA synthesis by blocking the enzyme thymidylate synthase. They are used primarily in cancer treatment to inhibit the growth of cancer cells, which rely on rapid DNA replication. Examples include 5-fluorouracil (administered intravenously), pemetrexed (also intravenous), and raltitrexe...
Report ID: 2549 |
Delivery: Immediate |
Published: June 2024 |
No. of Pages: 180
cDNA Clone Vectors Market Size is valued at USD 120.8 Mn in 2023 and is predicted to reach USD 258.1 Mn by the year 2031 at a 10.2% CAGR during the forecast period for 2024-2031. cDNA clone vectors are tools used in molecular biology to clone and express complementary DNA (cDNA) derived from messenger RNA (mRNA). These vectors typically contain elements such as promoter regions for gene expression, selection markers for identifying successfull...
Report ID: 2544 |
Delivery: Immediate |
Published: June 2024 |
No. of Pages: 180
Vitamin B12 API Market Size is predicted to grow at a 5.7% CAGR during the forecast period for 2024-2031. Vitamin B12(cobalamin) is a vital vitamin necessary for various important body processes, such as the creation of red blood cells as well as the synthesis of DNA. The API for vitamin B12 refers to the unadulterated form of the vitamin, typically acquired through chemical synthesis or fermentation. The active ingredient is responsible for t...
Report ID: 2536 |
Delivery: Immediate |
Published: June 2024 |
No. of Pages: 179
Pharmaceuticals